Correction of glycogen storage disease Ia in a murine model using a non-primate lentiviral vector

被引：0
|
作者：
Condiotti, Reba [1 ]
Grinshpun, Albert [1 ]
Peretz, Sima [2 ]
Chou, Janice [3 ]
Galun, Eithan [1 ]
机构：
[1] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel
[2] Harlan Biotech Israel Ltd, SPF Anim Facilities, Rehovot, Israel
[3] NIH, NICHHD, Heritable Disorders Branch, Bethesda, MD 20892 USA
来源：
HUMAN GENE THERAPY | 2007年 / 18卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1072 / 1073
页数：2
相关论文
共 50 条
  • [31] Correction of Metabolic Abnormalities in Murine Glycogen Storage Disease Type Ib by Gene Therapy
    Lee, Young Mok
    Kwon, Joonhyun
    Weinstein, David A.
    Chou, Janice Y.
    MOLECULAR THERAPY, 2015, 23 : S150 - S150
  • [32] Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
    Kang, Hye-Ri
    Waskowicz, Lauren
    Seifts, Andrea M.
    Landau, Dustin J.
    Young, Sarah P.
    Koeberl, Dwight D.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 : 265 - 273
  • [33] HIGHLY EFFICACIOUS GENE THERAPY IN THE CANINE MODEL FOR GLYCOGEN STORAGE DISEASE TYPE IA
    Luo, Xiaoyan
    Demaster, Amanda
    Crane, Bayley
    Pinto, C. R.
    Brown, T. T.
    Kozink, D. M.
    Bird, A.
    Kishnani, P. S.
    Koeberl, D. D.
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (03) : 221 - 222
  • [34] Correction of glycogen storage disease type III with rapamycin in a canine model
    Yi, Haiqing
    Brooks, Elizabeth D.
    Thurberg, Beth L.
    Fyfe, John C.
    Kishnani, Priya S.
    Sun, Baodong
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2014, 92 (06): : 641 - 650
  • [35] Correction of glycogen storage disease type III with rapamycin in a canine model
    Haiqing Yi
    Elizabeth D. Brooks
    Beth L. Thurberg
    John C. Fyfe
    Priya S. Kishnani
    Baodong Sun
    Journal of Molecular Medicine, 2014, 92 : 641 - 650
  • [36] Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy
    Yiu, Wai Han
    Lee, Young Mok
    Peng, Wen-Tao
    Pan, Chi-Jiunn
    Mead, Paul A.
    Mansfield, Brian C.
    Chou, Janice Y.
    MOLECULAR THERAPY, 2010, 18 (06) : 1076 - 1084
  • [37] Correction of metabolic abnormalities in a mouse model of glycogen storage disease type Ia by CRISPR/Cas9-based gene editing
    Arnaoutova, Irina
    Zhang, Lisa
    Chen, Hung-Dar
    Mansfield, Brian C.
    Chou, Janice Y.
    MOLECULAR THERAPY, 2021, 29 (04) : 1602 - 1610
  • [38] Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia
    Brooks, Elizabeth Drake
    Little, Dianne
    Arumugam, Ramamani
    Sun, Baodong
    Curtis, Sarah
    DeMaster, Amanda
    Maranzano, Michael
    Jackson, Mark W.
    Kishnani, Priya
    Freemark, Michael S.
    Koeberl, Dwight D.
    MOLECULAR GENETICS AND METABOLISM, 2013, 109 (02) : 161 - 170
  • [39] Hepatocytes Contribute to Residual Glucose Production in a Mouse Model for Glycogen Storage Disease Type Ia
    Hijmans, Brenda S.
    Boss, Andreas
    van Dijk, Theo H.
    Soty, Maud
    Wolters, Henk
    Mutel, Elodie
    Groen, Albert K.
    Derks, Terry G. J.
    Mithieux, Gilles
    Heerschap, Arend
    Reijngoud, Dirk-Jan
    Rajas, Fabienne
    Oosterveer, Maaike H.
    HEPATOLOGY, 2017, 66 (06) : 2042 - 2054
  • [40] DIET HIGHLY INFLUENCES THE DEVELOPMENT OF NEPHROPATHY IN A MOUSE MODEL OF GLYCOGEN STORAGE DISEASE TYPE Ia
    Gjorgjieva, Monika
    Clar, Julie
    Raffin, Margaux
    Duchampt, Adeline
    Stefanutti, Anne
    Mithieux, Gilles
    Rajas, Fabienne
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
12345